Page last updated: 2024-11-04

glucono-1,4-lactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Glucono-1,4-lactone (GDL) is a cyclic ester of gluconic acid. It is a white, crystalline solid that is soluble in water. GDL is produced by the fermentation of glucose by certain bacteria, such as Aspergillus niger. It is also synthesized commercially from starch. GDL is a versatile compound with a variety of applications, including as a food additive, a pharmaceutical ingredient, and a chemical intermediate. It is a weak acid that is used as an acidulant, a flavor enhancer, and a pH regulator in foods. GDL is also used in the production of pharmaceuticals, such as calcium gluconate, which is used to treat calcium deficiency. GDL is also used as a precursor to other chemicals, such as gluconic acid and gluconates. GDL is being studied for its potential health benefits. Some studies have shown that GDL may have antioxidant properties. It is also being investigated as a possible treatment for diabetes, obesity, and cancer. GDL is a safe and effective compound that has a wide range of applications. It is a valuable ingredient in many products, and it is being studied for its potential health benefits.'

Cross-References

ID SourceID
PubMed CID608
CHEBI ID5571
SCHEMBL ID1893475
MeSH IDM0277416

Synonyms (56)

Synonym
1,4-d-mannonolactone
nsc1971
mannonic acid, d-
d-mannono-(1.fwdarw.4)-lactone
.gamma.-lactone of mannonic acid
d-mannonic acid, .gamma.-lactone
d-galactonic acid, gamma-lactone
nsc-34392
nsc25282
nsc34392
d-galactonic acid, .gamma.-lactone
d-galactono-.gamma.-lactone
galactonic acid, d-
nsc102762
nsc-102762
.gamma.-d-galactonolactone
E40CCFF6-5987-45B5-B197-E4B919B073CB
FT-0693198
5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-dihydro-furan-2-one
l-galactono gamma-lactone, xxii
bdbm50070030
5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-one
SCHEMBL1893475
161168-87-2
FT-0624337
FT-0627838
FT-0627952
FT-0624545
FT-0625544
FT-0634484
5-(1,2-dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3h)-one (non-preferred name)
STL372824
AKOS015856415
d-gulonic acid-1,4-lactone
BBL033927
CHEBI:5571
23666-11-7
d-talono-1,4-lactone
d-allono-1,4-lactone
10238-03-6
VS-12344
29474-78-0
Q27106810
BCP33528
gamma-d-galactonolactone;1,4-d-galactonolactone
d-talonic acid gamma-lactone
d-talonic acid-1,4-lactone
d-gluconic acid-g-lactone pound>>gluconic acid-1,4-lactone pound>>d-gluconic acid, gamma-lactone
BCP17475
mfcd00080784
SY273558
EN300-187579
d-allonic acid gamma-lactone
d-idonic acid, gamma-lactone
glucono-1,4-lactone
SY066747

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Calcium D-glucarate is promoted as an orally bioavailability dietary supplement with potential chemopreventive activity without adverse effects."( A comparative study of antioxidative activity of calcium-D-glucarate, sodium-D-gluconate and D-glucono-1,4-lactone in a human blood platelet model.
Saluk-Juszczak, J, 2010
)
0.58
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
gamma-lactoneA lactone having a five-membered lactone ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prolyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)Ki20,000.00005.00007.66679.0000AID1799825
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (1)

Processvia Protein(s)Taxonomy
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
procollagen-proline 4-dioxygenase activityProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
iron ion bindingProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
L-ascorbic acid bindingProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
endoplasmic reticulum lumenProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
endoplasmic reticulumProlyl 4-hydroxylase subunit alpha-1Gallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1799825Inhibition Assay from Article : \\Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase.\\1986The Journal of biological chemistry, Jun-15, Volume: 261, Issue:17
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (8.33)18.7374
1990's1 (8.33)18.2507
2000's4 (33.33)29.6817
2010's5 (41.67)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.30 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index13.88 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]